Randomized Trial of Two Ablation Catheters in Paroxysmal Atrial Fibrillation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00678340|
Recruitment Status : Completed
First Posted : May 15, 2008
Last Update Posted : March 6, 2013
Atrial fibrillation (AF) is a chaotic heart rhythm of the top chambers of the heart. AF occurs in up to 10% of the population over the age of 60. It is associated with tiredness, impaired functional capacity and is the cause of up to 10% of strokes.
Ablation is a procedure performed with small tubes (catheters) that are introduced through the top of the leg. Burns are made inside of the heart to treat AF. This procedure has been shown to cure 90% of patients with intermittent (paroxysmal) AF.
The investigators currently use either one of two different catheters to create these burns inside the heart. The investigators do not know which is the best catheter to use in patients with paroxysmal atrial fibrillation.
The investigators study will randomly allocate patients to have their ablation performed by either one of the catheters to give a fair comparison between the two. The investigators objective is to study the differences between these two catheters.
|Condition or disease||Intervention/treatment||Phase|
|Atrial Fibrillation||Device: WACA and PVI Device: PVAC||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||178 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Single Centre, Randomized, Single Blinded Trial of Wide Area Circumferential Ablation With Pulmonary Vein Isolation Compared to a Multipolar, Circular Ablation Catheter in Patients With Paroxysmal Atrial Fibrillation|
|Study Start Date :||September 2007|
|Actual Primary Completion Date :||March 2013|
|Actual Study Completion Date :||March 2013|
Active Comparator: 1
WACA and PVI
Device: WACA and PVI
Wide area circumferential ablation (WACA) in the pulmonary vein antrum with subsequent pulmonary vein isolation (PVI) with a single tip irrigated catheter.
Active Comparator: 2
Circumferential ablation with a circular ablation catheter (Ablation Frontiers) to electrical silence.
Other Name: Pulmonary vein ablation catheter, Ablation Frontiers
- Freedom of AF at 1 year following AF ablation procedure measured by 7 day holter recording [ Time Frame: 1 year ]
- Procedural time for pulmonary vein isolation [ Time Frame: Index procedure ]
- All procedural complications [ Time Frame: Index ]
- Incidence of pulmonary vein stenosis measure by MRI at 6 months post procedure [ Time Frame: 6 months ]
- Quality of life questionnaire [ Time Frame: 6 months and 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00678340
|University College Hospital London NHS Foundation Trust|
|London, United Kingdom|
|Principal Investigator:||Pier D Lambiase, PhD||University College Hospital London NHS Foundation Trust|